Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand-Reference-Cited by-同舟云学术

Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand

Published:2012-07-25 Issue:15 Volume:55 Page:6968-6974
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Abdel-Aal Abu-Baker M.¹,El-Naggar Dina¹,Zaman Mehfuz¹,Batzloff Michael²,Toth Istvan¹³

Affiliation:

1. School of Chemistry and Molecular Biosciences (SCMB), The University of Queensland, QLD 4072, Queensland, Australia

2. Institute for Glycomics, Griffith University, Gold Coast, QLD 4215, Queensland, Australia

3. School of Pharmacy, The University of Queensland, St. Lucia, QLD 4072, Australia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300822g

Reference26 articles.

1. Possible functions of tumor-associated carbohydrate antigens

2. Cancer immunotherapy: moving beyond current vaccines

3. Immunity against cancer: lessons learned from melanoma

4. Fully Synthetic Carbohydrate-Based Vaccines in Biochemically Relapsed Prostate Cancer: Clinical Trial Results With α-N-Acetylgalactosamine-O-Serine/Threonine Conjugate Vaccine

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation Dengue Vaccines: Leveraging Peptide-Based Immunogens and Advanced Nanoparticles as Delivery Platforms;Journal of Pharmaceutical Sciences;2024-08

2. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines;Journal of Peptide Science;2024-04-03

3. Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens;ChemBioChem;2023-04-14

4. Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope;RSC Advances;2022

5. Recent progress in synthetic self-adjuvanting vaccine development;Biomaterials Science;2022